|Public (SASE: BSNLR)|
|Headquarters||Sarajevo, Bosnia and Herzegovina|
|Edin Arslanagić (Chief Executive Officer)|
|Products||Solid oral form medicines, ampule medicines, galenic products, non-pharmaceutical chemical products|
|Revenue||88,056 million BAM (2007)|
|7,796 million BAM (2007)|
Number of employees
Bosnalijek is the largest pharmaceutical company in Bosnia and Herzegovina. The organisation was established in 1951 and employs ~620 workers, out of which more than 50% have university level or higher qualifications. Its product portfolio consists of ~180 products. The company continues investment into R&D. Bosnalijek has established collaboration with several world-leading companies from the industry.
Bosnalijek is present in 22 countries worldwide: all neighbouring southeastern European countries, most eastern European countries, Libya and many French-speaking African countries, several countries from the Arabian peninsula and Caucasus, etc.
- Bosnalijek - 2007 financial report
- Short overview of Bosnalijek
- Bosnalijek worldwide
- Summary of Project Information, Project Number 24017[permanent dead link], International Finance Corporation, World Bank Group. Accessed 2008-01-14.
|Wikimedia Commons has media related to Bosnalijek.|
|This European corporation or company article is a stub. You can help Wikipedia by expanding it.|